Related Experiment Videos

Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: Achilles' Last Stand?

Daniel W Carlson¹, Ronald D Berger¹

¹Department of Medicine, Johns Hopkins University, Baltimore, Maryland.

JACC. Clinical Electrophysiology

|May 16, 2018

Abstract

No abstract available in PubMed .

Keywords:

device infection implantable cardioverter-deﬁbrillator shock inappropriate therapy subcutaneous implantable cardioverter transvenous implantable cardioverter-deﬁbrillator

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Effect of Left Atrial Size and Volume Reduction on Pulmonary Vein Isolation Efficacy in Patients With Persistent and Longstanding Persistent Atrial Fibrillation: Subset Analysis From the aMAZE Trial.

Circulation. Arrhythmia and electrophysiology·2026

Assessment of Intraprocedural Automated Arrhythmia Origin Localization System for Localizing Pacing Sites in 3D Space.

JACC. Clinical electrophysiology·2025

Lipomatous Metaplasia Facilitates Ventricular Tachycardia in Patients With Nonischemic Cardiomyopathy.

JACC. Clinical electrophysiology·2024

Lipomatous Metaplasia Is Associated With Ventricular Tachycardia Recurrence Following Ablation in Patients With Nonischemic Cardiomyopathy.

JACC. Clinical electrophysiology·2024

Pulmonary Vein Isolation With or Without Left Atrial Appendage Ligation in Atrial Fibrillation: The aMAZE Randomized Clinical Trial.

JAMA·2024

Twisted fiber microfluidics: a cutting-edge approach to 3D spiral devices.

Microsystems & nanoengineering·2024

See all related articles